The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Hybrid cell membrane-coated nanoparticles: A multifunctional biomimetic platform for cancer diagnosis and therapy
Abstract
Biomimetic nanotechnology through camouflaging synthetic nanoparticles (NPs) with natural cell membranes, which bestows with immune evasion and superior targeting capacity, has been extensively used in drug delivery systems (DDS) over the last decades. These biomimetic NPs not only retain the physicochemical features of the synthetic vehicles but also inherit the cell membranes' intrinsic functionalities. Combined with these benefits, optimized nano-biomimetic DDS allow maximum delivery efficacy. Compared to erythrocyte/cancer single cell membrane, the hybrid cell membrane expressing CD47 membrane protein and self-recognition molecules, from erythrocytes and cancer cells, provides remarkable features to the synthetic vehicles, such as immune evasion, long-term circulation, and homotypic targeting. In this review, we describe the preparation strategies, the camouflaging mechanism, and the antitumor applications of hybrid cell membrane-camouflaged NPs. Moreover, we discuss further modification of the hybrid cell membrane and the surface properties of fusion cellular membranes. Finally, we summarize the primary challenges and opportunities associated with these NPs. Statement of Significance Camouflaging synthetic nanoparticles with hybrid cell membrane has been extensively highlighted in recent years. The resultant biomimetic nanoparticles not only reserve the physicochemical properties of the synthetic nanoparticles but also inherit the biological functions of source cells. Compared with single cell membrane, hybrid cell membrane can endow synthetic nanoparticles with multiple biofunctions derived from the original source cells. To provide a timely review of this rapidly developing subject of research, this paper summarized recent progress on the hybrid cell membrane-camouflaged nanoparticles as drug delivery systems for cancer diagnosis and treatment. In this review, we focused primarily on five different types of hybrid cell membrane-camouflaged nanoparticles with the preparation strategies, the camouflaging mechanism, and the antitumor applications. Moreover, further modification of the hybrid cell membrane was also discussed for isolating effectively circulating tumor cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Siegel, R. L., Miller, K. D., & Jemal, A. (2020) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21590 · Cited by 20,444
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Nano based drug delivery systems: recent developments and future prospects
Patra, J. K., Das, G., Fraceto, L. F., Campos, E. V. R., Rodriguez-Torres, M. D. P., Acosta-Torres, L. S., Diaz-Torres, L. A., Grillo, R., Swamy, M. K., Sharma, S., et al. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0392-8 · Cited by 6,684
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
Suk, J. S., Xu, Q., Kim, N., Hanes, J., & Ensign, L. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.012 · Cited by 4,523
Impact of Nanotechnology on Drug Delivery
Farokhzad, O. C., & Langer, R. (2009) · ACS Nano · doi:10.1021/nn900002m · Cited by 3,348
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform
Hu, C.-M. J., Zhang, L., Aryal, S., Cheung, C., Fang, R. H., & Zhang, L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106634108 · Cited by 2,433
Maeda, H., Nakamura, H., & Fang, J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.10.002 · Cited by 2,376
Role of CD47 as a Marker of Self on Red Blood Cells
Oldenborg, P.-A., Zheleznyak, A., Fang, Y.-F., Lagenaur, C. F., Gresham, H. D., & Lindberg, F. P. (2000) · Science · doi:10.1126/science.288.5473.2051 · Cited by 1,970
Nanotechnology for Multimodal Synergistic Cancer Therapy
Fan, W., Yung, B., Huang, P., & Chen, X. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00258 · Cited by 1,791
Nanoparticle biointerfacing by platelet membrane cloaking
Hu, C.-M. J., Fang, R. H., Wang, K.-C., Luk, B. T., Thamphiwatana, S., Dehaini, D., Nguyen, P., Angsantikul, P., Wen, C. H., Kroll, A. V., et al. (2015) · Nature · doi:10.1038/nature15373 · Cited by 1,789
Wu, W., Wu, Z., Yu, T., Jiang, C., & Kim, W.-S. (2015) · Science and Technology of Advanced Materials · doi:10.1088/1468-6996/16/2/023501 · Cited by 1,574
The microbiome, cancer, and cancer therapy
Helmink, B. A., Khan, M. A. W., Hermann, A., Gopalakrishnan, V., & Wargo, J. A. (2019) · Nature Medicine · doi:10.1038/s41591-019-0377-7 · Cited by 1,200
Parodi, A., Quattrocchi, N., van de Ven, A. L., Chiappini, C., Evangelopoulos, M., Martinez, J. O., Brown, B. S., Khaled, S. Z., Yazdi, I. K., Enzo, M. V., et al. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2012.212 · Cited by 1,168
Dai, Y., Xu, C., Sun, X., & Chen, X. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00592f · Cited by 931
Chen, Z., Zhao, P., Luo, Z., Zheng, M., Tian, H., Gong, P., Gao, G., Pan, H., Liu, L., Ma, A., et al. (2016) · ACS Nano · doi:10.1021/acsnano.6b04695 · Cited by 895
Erythrocyte–Platelet Hybrid Membrane Coating for Enhanced Nanoparticle Functionalization
Dehaini, D., Wei, X., Fang, R. H., Masson, S., Angsantikul, P., Luk, B. T., Zhang, Y., Ying, M., Jiang, Y., Kroll, A. V., et al. (2017) · Advanced Materials · doi:10.1002/adma.201606209 · Cited by 769
Metabolic targets for cancer therapy
Galluzzi, L., Kepp, O., Heiden, M. G. V., & Kroemer, G. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4145 · Cited by 711
Yang, R., Xu, J., Xu, L., Sun, X., Chen, Q., Zhao, Y., Peng, R., & Liu, Z. (2018) · ACS Nano · doi:10.1021/acsnano.7b09041 · Cited by 698
Xia, Q., Zhang, Y., Li, Z., Hou, X., & Feng, N. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.01.011 · Cited by 665
Cell membrane-camouflaged nanoparticles for drug delivery
Luk, B. T., & Zhang, L. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.07.019 · Cited by 610
Gao, M., Liang, C., Song, X., Chen, Q., Jin, Q., Wang, C., & Liu, Z. (2017) · Advanced Materials · doi:10.1002/adma.201701429 · Cited by 590
Rao, L., Cai, B., Bu, L.-L., Liao, Q.-Q., Guo, S.-S., Zhao, X.-Z., Dong, W.-F., & Liu, W. (2017) · ACS Nano · doi:10.1021/acsnano.7b00133 · Cited by 561
Nanoparticles Coated with Neutrophil Membranes Can Effectively Treat Cancer Metastasis
Kang, T., Zhu, Q., Wei, D., Feng, J., Yao, J., Jiang, T., Song, Q., Wei, X., Chen, H., Gao, X., et al. (2017) · ACS Nano · doi:10.1021/acsnano.6b06477 · Cited by 551
Self-citationMagnetic iron oxide nanoparticles for drug delivery: applications and characteristics
Vangijzegem, T., Stanicki, D., & Laurent, S. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1554647 · Cited by 548
Cancer Cell Membrane‐Coated Upconversion Nanoprobes for Highly Specific Tumor Imaging
Rao, L., Bu, L., Cai, B., Xu, J., Li, A., Zhang, W., Sun, Z., Guo, S., Liu, W., Wang, T., et al. (2016) · Advanced Materials · doi:10.1002/adma.201506086 · Cited by 530
Wang, D., Dong, H., Li, M., Cao, Y., Yang, F., Zhang, K., Dai, W., Wang, C., & Zhang, X. (2018) · ACS Nano · doi:10.1021/acsnano.7b08355 · Cited by 515
Rao, L., Bu, L., Xu, J., Cai, B., Yu, G., Yu, X., He, Z., Huang, Q., Li, A., Guo, S., et al. (2015) · Small · doi:10.1002/smll.201502388 · Cited by 513
Modulating Antibacterial Immunity via Bacterial Membrane-Coated Nanoparticles
Gao, W., Fang, R. H., Thamphiwatana, S., Luk, B. T., Li, J., Angsantikul, P., Zhang, Q., Hu, C.-M. J., & Zhang, L. (2015) · Nano Letters · doi:10.1021/nl504798g · Cited by 509
Cell or Cell Membrane-Based Drug Delivery Systems
Tan, S., Wu, T., Zhang, D., & Zhang, Z. (2015) · Theranostics · doi:10.7150/thno.11852 · Cited by 466
Duan, X., Chan, C., Guo, N., Han, W., Weichselbaum, R. R., & Lin, W. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b09538 · Cited by 458
Cell membrane-based nanoparticles: a new biomimetic platform for tumor diagnosis and treatment
Li, R., He, Y., Zhang, S., Qin, J., & Wang, J. (2018) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2017.11.009 · Cited by 430
Guo, Y., Wang, D., Song, Q., Wu, T., Zhuang, X., Bao, Y., Kong, M., Qi, Y., Tan, S., & Zhang, Z. (2015) · ACS Nano · doi:10.1021/acsnano.5b01042 · Cited by 413
Luong, D., Kesharwani, P., Deshmukh, R., Mohd Amin, M. C. I., Gupta, U., Greish, K., & Iyer, A. K. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.07.015 · Cited by 408
Cancer drug delivery in the nano era: An overview and perspectives
Li, Z., Tan, S., Li, S., Shen, Q., & Wang, K. (2017) · Oncology Reports · doi:10.3892/or.2017.5718 · Cited by 406
Jiang, Q., Liu, Y., Guo, R., Yao, X., Sung, S., Pang, Z., & Yang, W. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.11.021 · Cited by 398
Recent advances of PLGA micro/nanoparticles for the delivery of biomacromolecular therapeutics
Ding, D., & Zhu, Q. (2018) · Materials Science and Engineering: C · doi:10.1016/j.msec.2017.12.036 · Cited by 386
Interfacial interactions between natural RBC membranes and synthetic polymeric nanoparticles
Luk, B. T., Jack Hu, C.-M., Fang, R. H., Dehaini, D., Carpenter, C., Gao, W., & Zhang, L. (2013) · Nanoscale · doi:10.1039/c3nr06371b · Cited by 375
Wang, Q., Ren, Y., Mu, J., Egilmez, N. K., Zhuang, X., Deng, Z., Zhang, L., Yan, J., Miller, D., & Zhang, H.-G. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3095 · Cited by 366
Macrophage Cell Membrane Camouflaged Mesoporous Silica Nanocapsules for In Vivo Cancer Therapy
Xuan, M., Shao, J., Dai, L., He, Q., & Li, J. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201500129 · Cited by 352
Red blood cell membrane-camouflaged melanin nanoparticles for enhanced photothermal therapy
Jiang, Q., Luo, Z., Men, Y., Yang, P., Peng, H., Guo, R., Tian, Y., Pang, Z., & Yang, W. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.07.027 · Cited by 332
Wei, X., Ying, M., Dehaini, D., Su, Y., Kroll, A. V., Zhou, J., Gao, W., Fang, R. H., Chien, S., & Zhang, L. (2018) · ACS Nano · doi:10.1021/acsnano.7b07720 · Cited by 329
Preparation and Application of Cell Membrane-Camouflaged Nanoparticles for Cancer Therapy
Zhai, Y., Su, J., Ran, W., Zhang, P., Yin, Q., Zhang, Z., Yu, H., & Li, Y. (2017) · Theranostics · doi:10.7150/thno.20118 · Cited by 312
A review of magnet systems for targeted drug delivery
Liu, Y.-L., Chen, D., Shang, P., & Yin, D.-C. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.03.031 · Cited by 298
Clearance of pathological antibodies using biomimetic nanoparticles
Copp, J. A., Fang, R. H., Luk, B. T., Hu, C.-M. J., Gao, W., Zhang, K., & Zhang, L. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1412420111 · Cited by 296
Cancer Cell Membrane-Coated Nanoparticles for Cancer Management
Harris, J. C., Scully, M. A., & Day, E. S. (2019) · Cancers · doi:10.3390/cancers11121836 · Cited by 278
Arginine dependence of tumor cells: targeting a chink in cancer’s armor
Patil, M. D., Bhaumik, J., Babykutty, S., Banerjee, U. C., & Fukumura, D. (2016) · Oncogene · doi:10.1038/onc.2016.37 · Cited by 265
Red blood cell membrane camouflaged magnetic nanoclusters for imaging-guided photothermal therapy
Ren, X., Zheng, R., Fang, X., Wang, X., Zhang, X., Yang, W., & Sha, X. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.03.026 · Cited by 260
Chai, Z., Hu, X., Wei, X., Zhan, C., Lu, L., Jiang, K., Su, B., Ruan, H., Ran, D., Fang, R. H., et al. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.08.027 · Cited by 253
Erythrocyte Membrane Modified Janus Polymeric Motors for Thrombus Therapy
Shao, J., Abdelghani, M., Shen, G., Cao, S., Williams, D. S., & van Hest, J. C. M. (2018) · ACS Nano · doi:10.1021/acsnano.8b01772 · Cited by 244
Rao, L., Meng, Q.-F., Bu, L.-L., Cai, B., Huang, Q., Sun, Z.-J., Zhang, W.-F., Li, A., Guo, S.-S., Liu, W., et al. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b14450 · Cited by 243
Engineering Cell Membrane‐Based Nanotherapeutics to Target Inflammation
Yan, H., Shao, D., Lao, Y., Li, M., Hu, H., & Leong, K. W. (2019) · Advanced Science · doi:10.1002/advs.201900605 · Cited by 240
Patel, R. B., Ye, M., Carlson, P. M., Jaquish, A., Zangl, L., Ma, B., Wang, Y., Arthur, I., Xie, R., Brown, R. J., et al. (2019) · Advanced Materials · doi:10.1002/adma.201902626 · Cited by 231
Self-citationBiomimetic Immuno‐Magnetosomes for High‐Performance Enrichment of Circulating Tumor Cells
Xiong, K., Wei, W., Jin, Y., Wang, S., Zhao, D., Wang, S., Gao, X., Qiao, C., Yue, H., Ma, G., et al. (2016) · Advanced Materials · doi:10.1002/adma.201601643 · Cited by 230
Rao, L., Meng, Q., Huang, Q., Wang, Z., Yu, G., Li, A., Ma, W., Zhang, N., Guo, S., Zhao, X., et al. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201803531 · Cited by 226
Platelet-membrane-biomimetic nanoparticles for targeted antitumor drug delivery
Wang, H., Wu, J., Williams, G. R., Fan, Q., Niu, S., Wu, J., Xie, X., & Zhu, L.-M. (2019) · Journal of Nanobiotechnology · doi:10.1186/s12951-019-0494-y · Cited by 222
Cell membrane-coated nanosized active targeted drug delivery systems homing to tumor cells: A review
He, Z., Zhang, Y., & Feng, N. (2020) · Materials Science and Engineering: C · doi:10.1016/j.msec.2019.110298 · Cited by 215
PLGA Nanoparticles Formed by Single- or Double-emulsion with Vitamin E-TPGS
McCall, R. L., & Sirianni, R. W. (2013) · Journal of Visualized Experiments · doi:10.3791/51015 · Cited by 208
Cell Membrane Coated Nanoparticles: next-generation Therapeutics
Narain, A., Asawa, S., Chhabria, V., & Patil-Sen, Y. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0225 · Cited by 207
Bu, L., Rao, L., Yu, G., Chen, L., Deng, W., Liu, J., Wu, H., Meng, Q., Guo, S., Zhao, X., et al. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201807733 · Cited by 206
Magnetic Iron Oxide Nanoparticles As Drug Carriers: Clinical Relevance
El-Boubbou, K. (2018) · Nanomedicine · doi:10.2217/nnm-2017-0336 · Cited by 201
Hollow Copper Sulfide Nanoparticle‐Mediated Transdermal Drug Delivery
Ramadan, S. S., Guo, L., Li, Y., Yan, B., & Lü, W. (2012) · Small · doi:10.1002/smll.201200783 · Cited by 188
Ashfaq, U. A., Riaz, M., Yasmeen, E., & Yousaf, M. Z. (2017) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.2017017845 · Cited by 158
Gao, C., Lin, Z., Wu, Z., Lin, X., & He, Q. Z. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b12865 · Cited by 156
Feng, Q., Yang, X., Hao, Y., Wang, N., Feng, X., Hou, L., & Zhang, Z. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b10948 · Cited by 155
Hybrid poly(lactic-co-glycolic acid) nanoparticles: design and delivery prospectives
Pandita, D., Kumar, S., & Lather, V. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.09.018 · Cited by 153
Microfluidic Synthesis of Rigid Nanovesicles for Hydrophilic Reagents Delivery
Zhang, L., Feng, Q., Wang, J., Sun, J., Shi, X., & Jiang, X. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201500096 · Cited by 151
Xu, J., Zhang, S., Machado, A., Lecommandoux, S., Sandre, O., Gu, F., & Colin, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-05184-5 · Cited by 139
Quantitative Analysis of the Enhanced Permeation and Retention (EPR) Effect
Wong, A. D., Ye, M., Ulmschneider, M. B., & Searson, P. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123461 · Cited by 137
Zhang, L., Li, R., Chen, H., Wei, J., Qian, H., Su, S., Shao, J., Wang, L., Qian, X., & Liu, B. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s126016 · Cited by 137
Self-citationIntrinsically active nanobody-modified polymeric micelles for tumor-targeted combination therapy
Talelli, M., Oliveira, S., Rijcken, C. J. F., Pieters, E. H. E., Etrych, T., Ulbrich, K., van Nostrum, R., Storm, G., Hennink, W. E., & Lammers, T. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.09.064 · Cited by 132
Cell membrane camouflaged nanoparticles: a new biomimetic platform for cancer photothermal therapy
Wu, M., Le, W., Mei, T., Wang, Y., Chen, B., Liu, Z., & Xue, C. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s200284 · Cited by 131
Self-citationZhang, L., Sheng, D., Wang, D., Yao, Y., Yang, K., Wang, Z., Deng, L., & Chen, Y. (2018) · Theranostics · doi:10.7150/thno.22430 · Cited by 130
Hou, L., Shan, X., Hao, L., Feng, Q., & Zhang, Z. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.03.005 · Cited by 128
Mitochondria‐Targeting Magnetic Composite Nanoparticles for Enhanced Phototherapy of Cancer
Guo, R., Peng, H., Tian, Y., Shen, S., & Yang, W. (2016) · Small · doi:10.1002/smll.201601094 · Cited by 127
Bose, R. J., Kim, B., Arai, Y., Han, I., Moon, J. J., Paulmurugan, R., Park, H., & Lee, S. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.08.018 · Cited by 127
Liu, C., Chen, G.-B., Chen, H.-H., Zhang, J., Li, H., Sheng, M., Weng, W.-B., & Guo, S. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.12.038 · Cited by 127
Self-citationPolo, E., Collado, M., Pelaz, B., & del Pino, P. (2017) · ACS Nano · doi:10.1021/acsnano.7b01197 · Cited by 118
He, X., Alves, C. S., Oliveira, N., et al. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2014.11.004 · Cited by 112
Hou, W., Xia, F., Alves, C. S., Qian, X., Yang, Y., & Cui, D. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b10772 · Cited by 112
Strategies in biomimetic surface engineering of nanoparticles for biomedical applications
Gong, Y., & Winnik, F. M. (2011) · Nanoscale · doi:10.1039/c1nr11297j · Cited by 107
Babiker, H. M., McBride, A., Newton, M., Boehmer, L., Drucker, A., Gowan, M., Cassagnol, M., Camenisch, T. D., Anwer, F., & Hollands, J. M. (2018) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2018.03.014 · Cited by 107
Chen, L., Wu, Y., Wu, H., Li, J., Xie, J., Zang, F., Ma, M., Gu, N., & Zhang, Y. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.07.017 · Cited by 99
Wang, Y., Luan, Z., Zhao, C., Bai, C., & Yang, K. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.105136 · Cited by 97
Self-citationChu, M., Hai, W., Zhang, Z., Wo, F., Wu, Q., Zhang, Z., Shao, Y., Zhang, D., Jin, L., & Shi, D. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.03.018 · Cited by 96
Leucocyte Membrane-Coated Janus Microcapsules for Enhanced Photothermal Cancer Treatment
He, W., Frueh, J., Wu, Z., & He, Q. Z. (2016) · Langmuir · doi:10.1021/acs.langmuir.5b04762 · Cited by 92
The Potential of Biomimetic Nanoparticles for Tumor-Targeted Drug Delivery
Li, B., Wang, F., Gui, L., He, Q. G., Yao, Y., & Chen, H. (2018) · Nanomedicine · doi:10.2217/nnm-2018-0017 · Cited by 92
Self-citationPlatelets and their biomimetics for regenerative medicine and cancer therapies
Li, Z., Hu, S., & Cheng, K. (2018) · Journal of Materials Chemistry B · doi:10.1039/c8tb02301h · Cited by 92
Polymer–iron oxide composite nanoparticles for EPR-independent drug delivery
Park, J., Kadasala, N. R., Abouelmagd, S. A., Castanares, M. A., Collins, D. S., Wei, A., & Yeo, Y. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.06.007 · Cited by 91
Enzyme-responsive doxorubicin release from dendrimer nanoparticles for anticancer drug delivery
Jeong, Y., Park, H. K., Lee, S. J., Oh, J., Lee, S., Lee, H. C., & Kang, D. H. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s87145 · Cited by 74
Cheng, X., Jin, Y. P., Sun, T., Qi, R., Li, H., & Fan, W. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.01.034 · Cited by 71
Erythrocytes in nanomedicine: an optimal blend of natural and synthetic materials
Zhang, H. (2016) · Biomaterials Science · doi:10.1039/c6bm00072j · Cited by 69
Biomimetic Microfluidic System for Fast and Specific Detection of Circulating Tumor Cells
Zhang, F., Wu, L., Nie, W., et al. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b03920 · Cited by 64
Zhao, Y., Lin, D., Wu, F., Guo, L., He, G., Ouyang, L., Song, X., Huang, W., & Li, X. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151017565 · Cited by 54
Self-citationSurface modification and local orientations of surface molecules in nanotherapeutics
Amin, M. L., Joo, J. Y., Yi, D. K., & An, S. S. A. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.04.017 · Cited by 53
Guigay, J., Tahara, M., Licitra, L. F., Keilholz, U., Friesland, S., Witzler, P., & Mesı́a, R. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00668 · Cited by 48
PEG/heparin-decorated lipid–polymer hybrid nanoparticles for long-circulating drug delivery
Sheng, Y., Chang, L., Kuang, T., & Hu, J. (2016) · RSC Advances · doi:10.1039/c5ra26215a · Cited by 32
Laminin-derived peptides: Applications in drug delivery systems for targeting
Negishi, Y., & Nomizu, M. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.05.017 · Cited by 31
Nanotechnology in Oral Cavity Carcinoma: Recent Trends and Treatment Opportunities
Felice, F. D., Cavallini, C., Barlattani, A., Tombolini, M., Brugnoletti, O., Tombolini, V., & Polimeni, A. (2019) · Nanomaterials · doi:10.3390/nano9111546 · Cited by 11
Cited by
Nanomedicine in cancer therapy
Fan, D., Cao, Y., Cao, M., Wang, Y., Cao, Y., & Gong, T. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01536-y · Cited by 878
Self-citationRecent progress in targeted delivery vectors based on biomimetic nanoparticles
Chen, L., Hong, W., Ren, W., Xu, T., Qian, Z., & He, Z. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00631-2 · Cited by 374
Ma, W., Yang, Y., Zhu, J., Jia, W., Zhang, T., Liu, Z., Chen, X., & Lin, Y. (2022) · Advanced Materials · doi:10.1002/adma.202109609 · Cited by 300
Cell membrane-coated nanoparticles: a novel multifunctional biomimetic drug delivery system
Liu, H., Su, Y.-Y., Jiang, X.-C., & Gao, J.-Q. (2023) · Drug Delivery and Translational Research · doi:10.1007/s13346-022-01252-0 · Cited by 302
Gong, J., Cheng, D., Liu, C., Wu, S., Sun, N., Zhao, L., Li, J., Xing, Y., & Zhao, J. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202404184 · Cited by 53
Metadata
- Authors
- Chen, H.-Y., Deng, J., Wang, Y., Wu, C.-Q., Li, X., & Dai, H.-W.
- Venue
- Acta Biomaterialia
- Publisher
- Elsevier BV
- Published
- 2020-08
- Volume
- 112
- Pages
- 1-13
- ISSN
- 1742-7061 (ISSN-L)
- OpenAlex
- W3028854163
- Cited by
- 402
- References
- 99
- FWCI
- 9.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.